Sartorius Aktiengesellschaft (OTCMKTS:SUVPF – Get Free Report) is expected to release its resultson Thursday, July 23rd. Analysts expect Sartorius Aktiengesellschaft to announce earnings of $1.55 per share and revenue of $1.0669 billion for the quarter.
Sartorius Aktiengesellschaft Stock Performance
Shares of SUVPF opened at $243.82 on Tuesday. The business’s 50-day moving average is $257.97 and its 200-day moving average is $267.71. Sartorius Aktiengesellschaft has a fifty-two week low of $208.00 and a fifty-two week high of $312.93.
Sartorius Aktiengesellschaft Company Profile
Sartorius Aktiengesellschaft is a global life science and laboratory equipment supplier headquartered in Göttingen, Germany. The company designs, manufactures and markets instruments and consumables that support research, development and production of biopharmaceuticals, vaccines and other high-value biologics. Its customer base spans academic and governmental research institutions as well as pharmaceutical and biotechnology firms.
Operations are structured into two core segments: Bioprocess Solutions and Lab Products & Services.
Read More
- Five stocks we like better than Sartorius Aktiengesellschaft
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Sartorius Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
